Da. Loblaw et al., Development and testing of a visit-specific patient satisfaction questionnaire: The Princess Margaret Hospital Satisfaction with Doctor Questionnaire, J CL ONCOL, 17(6), 1999, pp. 1931-1938
Purpose: To develop a psychometrically sound patient-satisfaction-with-phys
ician questionnaire that can be used in an outpatient oncology setting.
Patients and Methods: The questionnaire was developed by a four-step proces
s involving a total of 277 cancer patients, The item-generation process uti
lized input from 95 oncology outpatients, three medical researchers, and th
e relevant literature. Items were tested by 70 of the above patients, Initi
al item reduction was achieved by input from another eight patients, Factor
analysis and validity testing used data derived from a different group of
174 oncology outpatients, Convergent validity was tested by correlating the
Princess Margaret Hospital Patient Satisfaction with Doctor Questionnaire
(PMH/PSQ-MD) with Rubin et al's Physician subscale of the Patient's Viewpoi
nt Questionnaire (PS-PVQ) and Smith et al's Patient-Doctor Interaction Scal
e (PDIS), Divergent validity was tested by comparing these questionnaires w
ith Spitzer's quality of life (QOL) questionnaire.
Results: The final PMH/PSQ-MD is a 29-item self-administered questionnaire
with four response categories and a "does not apply" category, Four domains
were confirmed by factor analysis: (1) information exchange, (2) interpers
onal skills, (3) empathy, and (4) quality of time. The questionnaire hers o
n overall Cronbach's alpha of 0.97; the values for each domain are, respect
ively, 0.92, 0.90, 0.88, and 0.88, The PMH/PSQ-MD correlated well with both
the PDIS and the PS-PVQ (P < .001 for both), Divergent validity was confir
med with Spitzer's QOL questionnaire.
Conclusion: The PMH/PSQ-MD is an outpatient satisfaction questionnaire spec
ific to the patient-physician interaction that has shown excellent internal
consistency, is feasible, and has strong support for validity in this onco
logy population.
(C) 1999 by American Society of Clinical Oncology.